The Discounted Cash Flow (DCF) valuation of United Therapeutics Corp (UTHR) is 446.91 USD. With the latest stock price at 440.06 USD, the upside of United Therapeutics Corp based on DCF is 1.6%.
Based on the latest price of 440.06 USD and our DCF valuation, United Therapeutics Corp (UTHR) is a buy. buying UTHR stocks now will result in a potential gain of 1.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.8% | 8.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 349.24 - 650.71 | 446.91 |
| Upside | -20.6% - 47.9% | 1.6% |